Accelerating the future of protein therapeutics
Computational protein design and AI technology that accelerates biologics development — from antibodies to enzyme replacement therapies.
The Challenge
What partners are up against
Developing protein-based therapeutics is slow, expensive, and high-risk. Traditional discovery methods rely on screening vast libraries of variants, with success rates that leave enormous room for improvement.
Our Approach
How Arzeda delivers
Arzeda's platform computationally designs optimized protein therapeutics with specific functional properties. Our physics-based approach, combined with AI trained on 15+ years of proprietary data, accelerates the path from target to candidate.
Case study & results
Arzeda is collaborating with Takeda to accelerate protein biologics optimization using our computational design platform.